163 related articles for article (PubMed ID: 33792022)
1. [Application of the Risk of Bias 2 Tool].
Lee LL
Hu Li Za Zhi; 2021 Apr; 68(2):85-91. PubMed ID: 33792022
[TBL] [Abstract][Full Text] [Related]
2. Frequency of use and adequacy of Cochrane risk of bias tool 2 in non-Cochrane systematic reviews published in 2020: Meta-research study.
Babić A; Barcot O; Visković T; Šarić F; Kirkovski A; Barun I; Križanac Z; Ananda RA; Fuentes Barreiro YV; Malih N; Dimcea DA; Ordulj J; Weerasekara I; Spezia M; Žuljević MF; Šuto J; Tancredi L; Pijuk A; Sammali S; Iascone V; von Groote T; Poklepović Peričić T; Puljak L
Res Synth Methods; 2024 May; 15(3):430-440. PubMed ID: 38262609
[TBL] [Abstract][Full Text] [Related]
3. Adequacy of risk of bias assessment in surgical vs non-surgical trials in Cochrane reviews: a methodological study.
Barcot O; Boric M; Dosenovic S; Cavar M; Jelicic Kadic A; Poklepovic Pericic T; Vukicevic I; Vuka I; Puljak L
BMC Med Res Methodol; 2020 Sep; 20(1):240. PubMed ID: 32993499
[TBL] [Abstract][Full Text] [Related]
4. The revised Cochrane risk of bias tool for randomized trials (RoB 2) showed low interrater reliability and challenges in its application.
Minozzi S; Cinquini M; Gianola S; Gonzalez-Lorenzo M; Banzi R
J Clin Epidemiol; 2020 Oct; 126():37-44. PubMed ID: 32562833
[TBL] [Abstract][Full Text] [Related]
5. Risk of bias tools in systematic reviews of health interventions: an analysis of PROSPERO-registered protocols.
Farrah K; Young K; Tunis MC; Zhao L
Syst Rev; 2019 Nov; 8(1):280. PubMed ID: 31730014
[TBL] [Abstract][Full Text] [Related]
6. Cochrane risk of bias tool was used inadequately in the majority of non-Cochrane systematic reviews.
Puljak L; Ramic I; Arriola Naharro C; Brezova J; Lin YC; Surdila AA; Tomajkova E; Farias Medeiros I; Nikolovska M; Poklepovic Pericic T; Barcot O; Suarez Salvado M
J Clin Epidemiol; 2020 Jul; 123():114-119. PubMed ID: 32247026
[TBL] [Abstract][Full Text] [Related]
7. Risk of bias assessment of sequence generation: a study of 100 systematic reviews of trials.
Wuytack F; Regan M; Biesty L; Meskell P; Lutomski JE; O'Donnell M; Treweek S; Devane D
Syst Rev; 2019 Jan; 8(1):13. PubMed ID: 30621793
[TBL] [Abstract][Full Text] [Related]
8. Risk of bias judgments for random sequence generation in Cochrane systematic reviews were frequently not in line with Cochrane Handbook.
Barcot O; Boric M; Poklepovic Pericic T; Cavar M; Dosenovic S; Vuka I; Puljak L
BMC Med Res Methodol; 2019 Aug; 19(1):170. PubMed ID: 31382898
[TBL] [Abstract][Full Text] [Related]
9. The judgement of biases included in the category "other bias" in Cochrane systematic reviews of interventions: a systematic survey.
Babic A; Pijuk A; Brázdilová L; Georgieva Y; Raposo Pereira MA; Poklepovic Pericic T; Puljak L
BMC Med Res Methodol; 2019 Apr; 19(1):77. PubMed ID: 30971219
[TBL] [Abstract][Full Text] [Related]
10. Risk of Bias in Systematic Reviews of Non-Randomized Studies of Adverse Cardiovascular Effects of Thiazolidinediones and Cyclooxygenase-2 Inhibitors: Application of a New Cochrane Risk of Bias Tool.
Bilandzic A; Fitzpatrick T; Rosella L; Henry D
PLoS Med; 2016 Apr; 13(4):e1001987. PubMed ID: 27046153
[TBL] [Abstract][Full Text] [Related]
11. Practicalities of using a modified version of the Cochrane Collaboration risk of bias tool for randomised and non-randomised study designs applied in a health technology assessment setting.
Robertson C; Ramsay C; Gurung T; Mowatt G; Pickard R; Sharma P;
Res Synth Methods; 2014 Sep; 5(3):200-11. PubMed ID: 26052846
[TBL] [Abstract][Full Text] [Related]
12. Disagreements in risk of bias assessment for randomized controlled trials in hypertension-related Cochrane reviews.
Yao Y; Shen J; Luo J; Li N; Liao X; Zhang Y
Trials; 2024 Jun; 25(1):405. PubMed ID: 38907276
[TBL] [Abstract][Full Text] [Related]
13. Risk of bias assessments and reporting quality of systematic reviews and randomized controlled trials examining acupuncture for depression: An overview and meta-epidemiology study.
Luo S; Long Y; Xiao W; Wang X; Chen R; Guo Q; Liu J; Shao R; Du L; Chen M
J Evid Based Med; 2020 Feb; 13(1):25-33. PubMed ID: 32112515
[TBL] [Abstract][Full Text] [Related]
14. Risk of bias over time in updates of Cochrane oral health reviews.
Faggion CM; Aranda L; Pandis N; Alarcón MA; Diaz KT
J Dent; 2019 Jan; 80():63-68. PubMed ID: 30342067
[TBL] [Abstract][Full Text] [Related]
15. Risk of bias assessments for selective reporting were inadequate in the majority of Cochrane reviews.
Saric F; Barcot O; Puljak L
J Clin Epidemiol; 2019 Aug; 112():53-58. PubMed ID: 31009658
[TBL] [Abstract][Full Text] [Related]
16. High and unclear risk of bias assessments are predominant in diagnostic accuracy studies included in Cochrane reviews.
Di Girolamo N; Winter A; Meursinge Reynders R
J Clin Epidemiol; 2018 Sep; 101():73-78. PubMed ID: 29777798
[TBL] [Abstract][Full Text] [Related]
17. SYRCLE's risk of bias tool for animal studies.
Hooijmans CR; Rovers MM; de Vries RB; Leenaars M; Ritskes-Hoitinga M; Langendam MW
BMC Med Res Methodol; 2014 Mar; 14():43. PubMed ID: 24667063
[TBL] [Abstract][Full Text] [Related]
18. Overall bias methods and their use in sensitivity analysis of Cochrane reviews were not consistent.
Babic A; Vuka I; Saric F; Proloscic I; Slapnicar E; Cavar J; Poklepovic Pericic T; Pieper D; Puljak L
J Clin Epidemiol; 2020 Mar; 119():57-64. PubMed ID: 31734347
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the Cochrane Collaboration's tool for assessing the risk of bias in randomized trials: focus groups, online survey, proposed recommendations and their implementation.
Savović J; Weeks L; Sterne JA; Turner L; Altman DG; Moher D; Higgins JP
Syst Rev; 2014 Apr; 3():37. PubMed ID: 24731537
[TBL] [Abstract][Full Text] [Related]
20. Poor reliability between Cochrane reviewers and blinded external reviewers when applying the Cochrane risk of bias tool in physical therapy trials.
Armijo-Olivo S; Ospina M; da Costa BR; Egger M; Saltaji H; Fuentes J; Ha C; Cummings GG
PLoS One; 2014; 9(5):e96920. PubMed ID: 24824199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
